1 / 7

Cannabidiol (CBD) Market Size, Cost Structures, Growth rate and Forecasts to 2026

An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.

samvi
Télécharger la présentation

Cannabidiol (CBD) Market Size, Cost Structures, Growth rate and Forecasts to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cannabidiol (CBD) Market To Reach USD 16.32 Billion By 2026 With 27.7% CAGR

  2. Market Summary The growth of the market is driven by the increased R&D investment in the healthcare industry and rising acceptance of cannabis globally. Market Size – USD 1.04 Billion in 2018, Market Growth - CAGR of 27.7%, Market Trends – Increased R&D investment in the healthcare industry and rising acceptance of cannabis globally.

  3. Our Approach Our Approach Market Summary The Cannabidiol (CBD) Market is forecast to grow from USD 1.04 Billion in 2018 to USD 16.32 Billion by 2026, at a CAGR of 27.7%, during the forecast period. The market is primarily driven by the increase in the usage of cannabidiol (CBD) in medical application, supplements, beverages and skin care. As a wide-spectrum pharmaceutical therapy, the cannabidiol market place is likely to witness significant R&D investments in the pharmaceutical industry. For its potential in the treatment of a number of diseases, multiple scientific studies have shown promising results of cannabidiol. As a result, the cannabidiol market is marked by a significant cannabidiol therapy that receives FDA approval or moves forward in human clinical trials. Approval of EPIDIOLEX ® cannabidiol has become a landmark announcement as it is the very first FDA approval of cannabis sativa plant-derived drug and also validated some of cannabidiol's therapeutic benefits. Significant economic, political and legislative shifts across the global cannabinoid marketplace are also expected to impact approval. It is also expected that the Drug Enforcement Administration (DEA) will reschedule and change the cannabidiol compound classification in the near future. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/1373

  4. Our Approach Our Approach Market Summary Further key findings from the report suggest • The Cannabidiol (CBD) Market is forecasted to grow from USD 1.04 Billion in 2018 to USD 16.32 Billion by 2026, at a CAGR of 27.7%, during the forecast period. A rapidly rising population and higher urbanization have boosted global demand for processed food products, driving food demand. • On the basis of product, the market is segmented into food grade and therapeutic grade. The market for therapeutics is expected to hold the largest market share throughout the forecast period. It is expected to reach USD 9.30 Billion in 2026, at a CAGR of 27.4% during the forecast period. Due to its health benefits that help in the treatment of neuropsychiatric disorders, the therapeutic grade dominates the segment. CBD also has the potential to treat other chronic disorders that are also expected to boost the demand for the product. To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/cannabidiol-cbd-market

  5. Our Approach Our Approach Market Summary Key participants include CV Sciences (US), Isodiol International (Canada), Medical Marijuana (US), Aurora Cannabis (Canada), CBD American Shaman (US), Canopy Growth Corporation (Canada), IRIE CBD (US), The Supreme Cannabis Company (Canada), General Cannabis Corp. (US), Cannabis Sativa, Inc. (US), and Insys Therapeutics, Inc (US). For the purpose of this study, Reports and Data have segmented the market on the basis of form, routes of administration, product, application, source, end user and regional analysis. Form (Revenue, USD Million; 2016-2026) Solid Liquid Concentrated Oil Cream Routes of Administration (Revenue, USD Million; 2016-2026) Inhalation (Smoke or Vapor) Aerosol Spray Capsules Tincture Spray Others

  6. Our Approach Our Approach Market Summary Application (Revenue, USD Million; 2016-2026) Neurogenerative Disorder Fibromyalgia Diabetes Energy Drinks Protein Bars Others End Use (Revenue, USD Million; 2016-2026) Healthcare Food & Beverage Others Order Now: https://www.reportsanddata.com/checkout-form/1373

  7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related